logo
Book a meeting
MycRx

Myc Rx

Biotechnology, 3401 Princeton Pike, Austin, Texas, 08648, United States, 1-10 Employees

mycrxpharma.com

  • LinkedIn

phone no Phone Number: +15*********

Who is MYCRX

MycRx is developing oral, small molecule inhibitors that directly target Myc, oncology's 'mega target'. A key driver of all 'Hallmarks of Cancer', >1M new cancer patients are diagnosed an...

Read More

lock icon Get Full Access
map
  • 3401 Princeton Pike, Austin, Texas, 08648, United States Headquarters: 3401 Princeton Pike, Austin, Texas, 08648, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MYCRX

MycRx Org Chart and Mapping

Employees
Lydia Rono

Lydia Rono

Director of Chemistry

See Full Org Chart arrow
email-formate-icon
View Email Formats for MycRx
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding MycRx

Answer: MycRx's headquarters are located at 3401 Princeton Pike, Austin, Texas, 08648, United States

Answer: MycRx's phone number is +15*********

Answer: MycRx's official website is https://mycrxpharma.com

Answer: MycRx's revenue is $1 Billion and Over

Answer: MycRx's SIC: 8731

Answer: MycRx's NAICS: 541714

Answer: MycRx has 1-10 employees

Answer: MycRx is in Biotechnology

Answer: MycRx contact info: Phone number: +15********* Website: https://mycrxpharma.com

Answer: MycRx is developing oral, small molecule inhibitors that directly target Myc, oncology's 'mega target'. A key driver of all 'Hallmarks of Cancer', >1M new cancer patients are diagnosed annually with overexpressed Myc protein. MycRx compounds display potent cellular Myc target engagement driving profound transcriptional inhibition & on-target mechanistic profiles, resulting in compelling anti-cancer activity. Ready for Late Lead Optimization, our chemistry is on a clear path to development candidate nomination, underpinned by proprietary structural biology revealing a unique, druggable site, potentially a key breakthrough in drugging Myc. Originally based in Melbourne, Australia, MycRx closed a Series A US-led venture capital round and has restructured as a Delaware corporation, with a growing North American Management team.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access